TRANSFORMING PAKISTAN'S MEDICAL LANDSCAPE THE CONVERGENCE OF PHYSIOLOGY, PHARMACOLOGY, AND HISTOPATHOLOGY FROM DIGITAL PIONEERING TO COMPUTATIONAL EXCELLENCE

Main Article Content

Dr Saima Nadeem
Dr Fiaz Ahmad
Dr Sofia Jadoon
Dr Nighat Parveen
Dr Bilquees Saba
Dr Saima Bashir

Keywords

Digital Technologies, Medical Education, Khyber Pakhtunkhwa, Digital Integration, Educational Challenges

Abstract

Background: Teaching and clinical procedures are changing as a result of the use of digital and computational technology in medical education. This research looks at how digital technology is now being used in the departments of physiology, pharmacology, and histology at medical institutions in Khyber Pakhtunkhwa (KPK), Pakistan.


Methods: A survey of 227 students from public (Khyber Medical College, Ayub Medical College) and private (Rehman Medical College, Peshawar Medical College, Frontier Medical College) medical schools was part of the mixed-methods technique that was used. The availability, application, and perceived advantages of digital technologies were evaluated in the survey. Thirty stakeholders participated in semi-structured interviews that yielded qualitative insights on opportunities and problems.


Results: Seventy-two percent of respondents said they had access to digital materials; availability was greater in public institutions (78.1%) than in private colleges (63.4%). The most frequent users of digital tools were found in the fields of histology (70.8%), physiology (63.9%), and pharmacology (54.8%). Improved learning outcomes (81.5%) and diagnostic accuracy (77.3%) were among the benefits. Reluctance to change (48.3%), insufficient training (58.2%), and few resources (65.9%) were among the obstacles. Senior faculty members at public universities were more resistant to them, while financial restrictions plagued private schools.


Conclusion: Digital technologies are improving medical education in KPK, but to fully realize their potential and get beyond current obstacles, increased training and strategic expenditures are required.


 

Abstract 94 | pdf Downloads 24

References

1. Garg M, Sethi G, Pandey AK, editors. Transcription and Translation in Health and Disease. Elsevier; 2023 Jan 30.
2. Jin YW. Deconvolution of bulk gene expression profiles to characterize the tumour immune landscape of early onset breast cancer.
3. Antonio M, Francesco L, Luigi A. PREPARATION AND PHYSICO-CHEMICAL CHARACTERIZATION OF KETANSERIN-LOADED LIPOSOMES FOR GLAUCOMA. CAMPOBASSO, DECEMBER 19 2022 thth. 2022 Dec 19:18.
4. Dhar J, Hazra A, Patra R, Kumar V, Subramaniyan V, Kumarasamy V, Mitra AK, Sayed AA, Aleya L, El-Demerdash FM, Almutairi MH. Unveiling Curvularia tuberculata-induced leaf anomalies in Rhododendron ferrugineum: implications in cultural-ecological conservation and harnessing microbial intervention in socio-economic advancement. Frontiers in Microbiology. 2024 Jan 11;14:1280120.
5. Cybil KV, editor. Biopolitics and Healing in a Mass Milieu. Taylor & Francis; 2023 Aug 25.
6. Sharma S, Chauhan J, Mandela Y, Hemavathy AT, Ballari HS. INSIGHTS INTO AGRICULTURE SCIENCES.
7. Bawa R, Chang EH, Audette GF, Diwan A, Faiz SA. Advances in Medical Biochemistry, Genomics, Physiology, and Pathology. Jenny Stanford Publishing; 2021 Dec 22.
8. Fertig B. Metabolism and Medicine: The Metabolic Landscape of Health and Disease (Volume 2). CRC Press; 2022 Jan 31.
9. Bizzarri M, Minini M, Monti N. Revisiting the Concept of Human Disease: Rethinking the Causality Concept in Pathogenesis for Establishing a Different Pharmacological Strategy. Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine. 2020:1-34.
10. Park SO. CONVERGENCE STRATEGY OF DIGITAL LIVESTOCK SYSTEM AND ANIMAL BIOMODELS FOR HUMAN WELLNESS IN FUTURE: A REVIEW. JAPS: Journal of Animal & Plant Sciences. 2024 Jan 1;34(1).
11. Khan M, Spicer J. The evolving landscape of cancer therapeutics. Concepts and Principles of Pharmacology: 100 Years of the Handbook of Experimental Pharmacology. 2019:43-79.
12. Van Hasselt JC, Iyengar R. Systems pharmacology: defining the interactions of drug combinations. Annual review of pharmacology and toxicology. 2019 Jan 6;59(1):21-40.
13. Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KS, Gückel B, Jačan A. Advancing biomarker development through convergent engagement: summary report of the 2nd International danube symposium on biomarker development, molecular imaging and applied diagnostics; March 14–16, 2018; Vienna, Austria. Molecular imaging and biology. 2020 Feb;22:47-65.
14. Giacomini A, Grillo E, Rezzola S, Ribatti D, Rusnati M, Ronca R, Presta M. The FGF/FGFR system in the physiopathology of the prostate gland. Physiological reviews. 2021 Apr 1;101(2):569-610.
15. Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Buneman OP. The concise guide to pharmacology 2021/22: Introduction and other protein targets. British journal of pharmacology. 2021 Oct;178:S1-26.
16. Sergi CM. Digital pathology: the time is now to bridge the gap between medicine and technological singularity. Interactive Multimedia-Multimedia Production and Digital Storytelling. 2019 Feb 13.
17. Hassell LA, Absar SF, Chauhan C, Dintzis S, Farver CF, Fathima S, Glassy EF, Goldstein JA, Gullapalli R, Ho J, Koch LK. Pathology education powered by virtual and digital transformation: now and the future. Archives of Pathology & Laboratory Medicine. 2023 Apr 1;147(4):474-91.
18. Wan S, Coveney PV. Introduction to Computational Biomedicine. InHigh Performance Computing for Drug Discovery and Biomedicine 2023 Sep 14 (pp. 1-13). New York, NY: Springer US.
19. Koivumäki JT, Hoffman J, Maleckar MM, Einevoll GT, Sundnes J. Computational cardiac physiology for new modelers: Origins, foundations, and future. Acta Physiologica. 2022 Oct;236(2):e13865.
20. Pun S, Haney LC, Barrile R. Modelling human physiology on-chip: historical perspectives and future directions. Micromachines. 2021 Oct 15;12(10):1250.